Citadel Advisors’s Ambev ABEV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABEV
SCP
BIP
NAMI
Citadel Advisors's ABEV Position: Q1 2026 in Review
Citadel Advisors increased its Ambev (ABEV) stake by 80% in Q1 2026, buying an estimated $8.28M and bringing the position to 6,526,986 shares worth $19.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2392.
Citadel Advisors first reported a position in ABEV in Q1 2014 and has held it in 44 quarters since. The position peaked at $46.9M in Q2 2020. 402 funds tracked by Wall St. Rank hold ABEV as of Q1 2026.
- Citadel Advisors held 6,526,986 shares of Ambev worth $19.1M as of Q1 2026.
- Citadel Advisors bought 2,898,174 Ambev shares in Q1 2026, an estimated $8.28M.
- Ambev made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2392 holding.
- Citadel Advisors first reported a position in Ambev in Q1 2014 and has held it in 44 quarters since.
- Citadel Advisors's Ambev position peaked at $46.9M in Q2 2020.
- 402 funds tracked by Wall St. Rank held Ambev as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.